Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X6XH
|
|||
| Former ID |
DNCL003120
|
|||
| Drug Name |
CM-2395
|
|||
| Indication | Schizophrenia [ICD-11: 6A20] | Phase 3 | [1] | |
| Company |
Cenomed BioSciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Pharmaceutical Research Companies Are Developing More Than 300 Medicines to Treat Mental Illnesses. Pharmaceutical Research and Manufacturers of America report.2010. | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031127) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.